TWi Biotechnology, Inc. (TPEX:6610)
Taiwan · Delayed Price · Currency is TWD 28.30
-0.40 (-1.39%)
May 8, 2026, 1:59 PM CST
TWi Biotechnology Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
23
Market Cap
3.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 66.40M | 65.15M | 5,228.81% |
| Dec 31, 2020 | 1.25M | -8.42M | -87.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Apex Biotechnology | 1.94B |
| SYN-TECH Chem. & Pharm. | 1.30B |
| Chunghwa Chemical Synthesis & Biotech | 804.88M |
| Genovate Biotechnology | 492.41M |
| HeXun Biosciences | 293.23M |
| BioGend Therapeutics | 229.81M |
| Intech Biopharm | 107.53M |
| Shine-On BioMedical | 30.00M |